ReGenesys

Foundation date

17/10/2005

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

ReGenesys BV is a wholly-owned subsidiary of Athersys, Inc. (NASDAQ: ATHX), a biotechnology company in Cleveland, Ohio, U.S.A., that is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product initially for disease indications in the neurological, cardiovascular, inflammatory and immune areas.  Athersys has several ongoing clinical trials to evaluate its MultiStem product candidate.

Upcoming events

Latest news

  • Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

    6 hours ago

  • Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology

    1 day ago

  • Fat creates an ideal environment for metastatic breast tumors

    1 day ago